MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,822,149 | -2.3% | 3,738,100 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $4,934,292 | +192.6% | 3,738,100 | +56.7% | 0.01% | +125.0% |
| Q1 2023 | $1,686,381 | +5.3% | 2,385,600 | +11.7% | 0.00% | -33.3% |
| Q4 2022 | $1,601,700 | -12.9% | 2,135,600 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $1,839,000 | -5.4% | 2,135,600 | +23.0% | 0.01% | +20.0% |
| Q2 2022 | $1,944,000 | -10.3% | 1,735,600 | -10.3% | 0.01% | +25.0% |
| Q1 2022 | $2,168,000 | -30.0% | 1,935,600 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $3,097,000 | -33.9% | 1,935,600 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $4,684,000 | -23.7% | 1,935,600 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $6,136,000 | -5.9% | 1,935,600 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $6,523,000 | -5.9% | 1,935,600 | 0.0% | 0.01% | -9.1% |
| Q4 2020 | $6,929,000 | – | 1,935,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
| Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
| Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
| Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
| Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
| DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
| Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
| Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |